Summary
A procedure for protoplast isolation and plant regeneration of St. John's wort has been developed to utilize cell-to-cell variability for optimum production of valuable medicinal compounds. Calluses, induced from hypocotyl segments of St. John's wort seedlings, were used for protoplast isolation, induction of sustained cell division, and ultimately, plant regeneration. Callus-isolated protoplasts at a density of 2.0×105 per ml were embedded in 0.6% Na-alginate blocks and cultured in a medium containing modified Murashige and Skoog (MS) salts, 2.5 μM 6-benzylaminopurine (BA), 5.0 μMα-naphthaleneacetic acid (NAA), and 0.5 moll−1 glucose. Protoplast-derived colonies formed compact calluses when transferred onto 0.35% gellan gum-solidified MS medium supplemented with 2.5 μM BA and 2.5 μM NAA. Shoot organogenesis from the protoplast-derived callus was induced on MS medium supplemented with 5 μM thidiazuron. Complete plantlets were obtained from the regenerated shoots on MS basal medium. A greater than 3-fold variation of antioxidant activity was observed among the protoplast-derived plantets and chemically distinct germplasm lines were selected on the basis of phytochemical profiles. The protoplast to plant regeneration protocol developed in this study provides the foundation for development of novel genotypes with potential expansion of the genetic diversity through somatic hybridization, and organelle transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brutovska, R.; Cellarova, E.; Dolezel, J. Cytogenetic variation of in vitro regenerated Hypericum perforatum L. plants and their seed progenies. Plant Sci. 133:221–229; 1998.
Cellarova, E.; Brutovska, R.; Daxnerova, Z. Correlation between hypericin content and the ploidy of somaclones of Hypericum perforatum L. Acta Biotechnol. 17:83–90; 1997.
Chupeau, M. C.; Lemoine, M.; Chupeau, Y. Requirement of thidiazuron for healthy protoplast development to efficient plant regeneration of a hybrid poplar (Populus tremula × Populus alba). J. Plant Physiol. 141:601–609; 1993.
Cott, J. M. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 30:108–112; 1997.
Davey, M. R.; Anthony, P.; Power, J. B.; Lowe, K. C. Plant protoplast technology: status and applications. In Vitro Cell. Dev. Biol. Plant 41: 202–212; 2005.
Dias, A. C. P. The potential of in vitro cultures of Hypericum perforatum and of Hypericum androsaemum to produce interesting pharmaceutical compounds. In: Ernst, E., ed. Hypericum: the genus Hypericum. Medicinal and aromatic plants—industrial profiles, vol. 31. London: Taylor & Francis; 2003:137–154.
Ellgehausen, K.; Schaffner, W.; Berger Buter, K. Isolierung, kultivierung und regeneration aus protoplaten oberer sprossabschnitte von Hypericum perforatum. Vortr. Pflanzenzuchtg. 42:148–186; 1998.
Gamborg, O. L.; Miller, R. A.; Ojima, K. Nutrient requirements of suspension cultures of soybean root cells. Exp. Cell Res. 50:151–158; 1968.
Gray, D. E.; Rottinghaus, G. E.; Garrett, H. E. G.; Pallardy, G. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography. J. AOAC Int. 83:944–949; 2000.
Grosser, J. W.; Gmitter, F. G. Jr. Applications of somatic hybridization and cybridization in crop improvement, with citrus as a model. In Vitro Cell. Dev. Biol. Plant 41:220–225; 2005.
Hansgen, K. D.; Vesper, J.; Ploch, M. Multicenter double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. J. Geriatr. Psychiatry Neurol. 7:S15-S18; 1994.
Jurgenliemk, G.; Nahrstedt, A. Phenolic compounds from Hypericum perforatum. Planta Med. 68:88–91; 2002.
Kirakosyan, A.; Sirvent, T. M.; Gibson, D. M.; Kaufman, P. B. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum). Biotechnol. Appl. Biochem. 39:71–81; 2004.
Koperdakova, J.; Brutovska, R.; Cellarova, E. Reproduction pathway analysis of several Hypericum perforatum L. somaclonal families. Hereditas 140:34–41; 2004.
Linde, K.; Ramirez, G.; Mulrow, C. D. St. John's wort for depression—an overview and meta-analysis of randomized clinical trials. Br. Med. J. 313:253–258; 1996.
Liu, F. F.; Ang, C. R. W.; Springer, D. Optimization of extraction conditions for active components in Hypericum perforatum using response surface methodology. J. Agric. Food Chem. 48:3364–3371; 2000.
Mannila, M.; Kim, H.; Isaacson, C. Optimization of supercritical fluid extraction for the separation of hyperforin and adhyperforin in St. John's wort (Hypericum perforatum L.). Green Chem. 4:331–336; 2002.
Miller, A. L. St. John's wort (Hypericum perforatum): clinical effects on depression and other conditions. Altern. Med Rev. 3:18–25; 1998.
Murashige, T.; Skoog, F. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol. Plant. 15:473–497; 1962.
Murch, S. J.; Choffe, K. L.; Victor, J. M. R.; Slimmon, T. Y.; KrishnaRaj, S.; Saxena, P. K. Thidiazuron-induced regeneration from hypocotyl cultures of St. John's wort (Hypericum perforatum cv. Anthos). Plant Cell Rep. 19:576–581;2000.
Murch, S. J.; Rupasinghe, H. P. V.; Saxena, P. K. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's Wort (Hypericum perforatum L. cv New Stem). Planta Med. 68:1–5; 2002.
Murch, S. J.; Saxena, P. K. Somatic cell fusion: relevance to medicinal plants. In: Saxena, P. K., ed, Development of plant-based medicines: conservation, efficacy and safety. Dordrecht: Kluwer Academic Publishers; 2000:167–182.
Nagata, T.; Takehe, I. Plating of isolated mesophyll protoplasts on agar medium. Planta 99:12–20; 1971.
Pan, Z. G.; Liu, C. Z.; Zobayed, S. M. A.; Saxena, P. K. Plant regeneration from mesophyll protoplasts of Echinacea purpurea. Plant Cell Tiss. Organ Cult. 77:251–255; 2004.
Patat-Ochatt, E. M.; Ochatt, S. J.; Power, J. B. Plant regeneration from protoplasts of apple rootstocks and scion varieties. J. Plant Physiol. 133:460–465; 1988.
Schempp, C. M.; Kirkin, V.; Simon-Haarhaus, B.; Kersten, A.; Kiss, J.; Termeer, C. C.; Gilb, B.; Kaufmann, T.; Borner, C.; Sleeman, J. P.; Simon, J. C. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21:1242–1250; 2002.
Sommer, H.; Harrer, G. Placeho-controlled double-blind study examining the effectiveness of a Hypericum preparation in 105 mildly depressed patients. J. Geriatr. Psychiatry Neurol. 7:S9-S11; 1994.
Takahata, Y.; Ohnishi-Kameyama, M.; Furuta, S.; Takahashi, M.; Suda, I. Highly polymerized procyanidins in brown soybean seed coat with a high radical-scavenging activity. J. Agric. Food Chem. 49:5843–5847; 2001.
Widholm, J. M. The use of fluorescein diacetate and phenosafranine for determining viability of cultured plant cells. Stain Technol. 47:189–194; 1972.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pan, Z.G., Liu, C.Z., Murch, S.J. et al. 2004 SIVB Congress Symposium Proceedings “Thinking Outside the Cell”: Optimized Chemodiversity in Protoplast-derived Lines of St. John's Wort (Hypericum perforatum L.). In Vitro Cell.Dev.Biol.-Plant 41, 226–231 (2005). https://doi.org/10.1079/IVP2004635
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1079/IVP2004635